Influenza
6
Companies
12
Drug Programs
2
Phase 3
0
Upcoming PDUFAs
Moderna
mFlusiva
Moderna
Moderna mRNA flu shot
Moderna
Moderna flu shot
Moderna
Moderna mRNA flu vaccine
Moderna
Moderna flu vaccine
Sanofi
A/H1N1 pandemic influenza vaccine (non- adjuvanted)
BioNTech SE
Influenza and COVID-19 Combination A
PharmaMar, S.A.
Recombinant Influenza HA Vaccine (H5N1)
BioNTech SE
Investigational COVID-19 Vaccine
Novartis AG
Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008
Moderna
mRNA Flu vaccine
Roche
Roche influenza treatment
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| MRNA Moderna | mFlusiva | Approved | — | — | — |
| MRNA Moderna | Moderna mRNA flu shot | Approved | — | — | — |
| MRNA Moderna | Moderna flu shot | Approved | — | — | — |
| MRNA Moderna | Moderna mRNA flu vaccine | Approved | — | — | — |
| MRNA Moderna | Moderna flu vaccine | Approved | — | — | — |
| SNY Sanofi | A/H1N1 pandemic influenza vaccine (non- adjuvanted) | Phase 3 | — | — | — |
| BNTX BioNTech SE | Influenza and COVID-19 Combination A | Phase 3 | — | — | — |
| PHM.MC PharmaMar, S.A. | Recombinant Influenza HA Vaccine (H5N1) | Phase 2 | — | — | — |
| BNTX BioNTech SE | Investigational COVID-19 Vaccine | Phase 2 | — | — | — |
| NVS Novartis AG | Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008 | Phase 2 | — | — | — |
| MRNA Moderna | mRNA Flu vaccine | — | — | — | — |
| RHHBY Roche | Roche influenza treatment | — | — | — | — |
Not financial advice
Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.